| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2552438 | Life Sciences | 2009 | 8 Pages |
Abstract
The results of the present study suggest that tamoxifen and raloxifene may have the potential to produce CTA in breast cancer patients receiving chemoprevention care.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Melissa A. Fudge, Martin Kavaliers, John-Paul Baird, Klaus-Peter Ossenkopp,